1.Toxicology and tissue distribution of Ruthenium (II) CO-releasing molecules and its interaction with endogenous substances.
Peng-peng WANG ; Hua-peng LIU ; Quan-yi ZHAO ; Yong-lin CHEN ; Bin LIU ; Bao-ping ZHANG ; Qian ZHENG
Acta Pharmaceutica Sinica 2013;48(11):1677-1687
Carbon monoxide has been proved to be an important signal molecule in body. Transition metal carbonyl compounds are solidified form of carbon monoxide. Numerous studies have shown that Ruthenium carbonyl carbon monoxide releasing molecules have a strong pharmacological activity. In this paper, five Ruthenium (II) carbonyl CORMs 1-5 were synthesized and their toxicology, tissue distribution and interaction with blood endogenous substances were investigated. The results showed CORMs' IC50 to fibroblasts are ranged from 212.9 to 2089.2 micromol x L(-1). Their oral LD50 to mouse is between 800 to 1600 mg x kg(-1). After repeated administration, CORMs 1 and CORMs 5 haven't shown an obvious influence to rats' liver and kidney function, but caused the injury to liver and kidney cells. The in vivo distribution result revealed the majority of CORMs were distributed in blood, liver and kidney, only a small part of CORMs distributed in lung, heart and spleen. They could scarcely cross the blood-brain barrier and distribute to brain. The non-CO ligands in structure have an obvious relevance to their in vivo absorption and distribution. Interestingly, CORMs could enhance the fluorescence of bovine serum albumin, and this enhancement was in direct proportion with the concentration of CORMs. Under different conditions, interaction of CORMs with glutathione got different type of products, one is Ruthenium (II) tricarbonyl complexes, and Ruthenium (II) dicarbonyl complexes.
Animals
;
Carbon Monoxide
;
chemistry
;
pharmacokinetics
;
toxicity
;
Fibroblasts
;
drug effects
;
Kidney
;
drug effects
;
Liver
;
drug effects
;
Mice
;
Molecular Structure
;
Organometallic Compounds
;
chemical synthesis
;
chemistry
;
pharmacokinetics
;
toxicity
;
Rats
;
Rats, Wistar
;
Ruthenium
;
chemistry
;
pharmacokinetics
;
toxicity
;
Tissue Distribution
2.Clinical use of a ceramide-based moisturizer for treating dogs with atopic dermatitis.
Ji Young JUNG ; Eui Hwa NAM ; Seol Hee PARK ; Seung Hee HAN ; Cheol Yong HWANG
Journal of Veterinary Science 2013;14(2):199-205
In humans, skin barrier dysfunction is thought to be responsible for enhanced penetration of allergens. Similar to conditions seen in humans, canine atopic dermatitis (CAD) is characterized by derangement of corneocytes and disorganization of intercellular lipids in the stratum corenum (SC) with decreased ceramide levels. This study was designed to evaluate the effects of a moisturizer containing ceramide on dogs with CAD. Dogs (n = 20, 3~8 years old) with mild to moderate clinical signs were recruited and applied a moisturizer containing ceramide for 4 weeks. Transepidermal water loss (TEWL), skin hydration, pruritus index for canine atopic dermatitis (PICAD) scores, and canine atopic dermatitis extent and severity index (CADESI) scores of all dogs were evaluated. Skin samples from five dogs were also examined with transmission electron microscopy (TEM) using ruthenium tetroxide. TEWL, PICAD, and CADESI values decreased (p < 0.05) and skin hydration increased dramatically over time (p < 0.05). Electron micrographs showed that the skin barrier of all five dogs was partially restored (p < 0.05). In conclusion, these results demonstrated that moisturizer containing ceramide was effective for treating skin barrier dysfunction and CAD symptoms.
Animals
;
Ceramides/*therapeutic use
;
Cholesterol/*therapeutic use
;
Dermatitis, Atopic/complications/drug therapy/physiopathology/*veterinary
;
Dog Diseases/*drug therapy/etiology/physiopathology
;
Dogs
;
Emollients/*therapeutic use
;
Epidermis/drug effects/physiopathology/ultrastructure
;
Fatty Acids, Nonesterified/*therapeutic use
;
Female
;
Male
;
Microscopy, Electron, Transmission/veterinary
;
Pruritus/drug therapy/etiology/physiopathology/veterinary
;
Republic of Korea
;
Ruthenium Compounds/chemistry
;
Water Loss, Insensible/drug effects